PTB (polypyrimidine tract-binding protein) is an abundant and widely expressed RNA-binding protein with four RRM (RNA recognition motif) domains. PTB is involved in numerous post-transcriptional steps in gene expression in both the nucleus and cytoplasm, but has been best characterized as a regulatory repressor of some ASEs (alternative splicing events), and as an activator of translation driven by IRESs (internal ribosome entry segments). We have used a variety of approaches to characterize the activities of PTB and its molecular interactions with RNA substrates and protein partners. Using splice-sensitive microarrays we found that PTB acts not only as a splicing repressor but also as an activator, and that these two activities are determined by the location at which PTB binds relative to target exons. We have identified minimal splicing repressor and activator domains, and have determined high resolution structures of the second RRM domain of PTB binding to peptide motifs from the co-repressor protein Raver1. Using single-molecule techniques we have determined the stoichiometry of PTB binding to a regulated splicing substrate in whole nuclear extracts. Finally, we have used tethered hydroxyl radical probing to determine the locations on viral IRESs at which each of the four RRM domains bind. We are now combining tethered probing with single molecule analyses to gain a detailed understanding of how PTB interacts with pre-mRNA substrates to effect either repression or activation of splicing.
PTB splicing maps
PTB has been investigated as a splicing repressor in numerous model systems, allowing a number of general principles about its mode of action to be discerned. A number of models have been suggested to explain, in whole or part, PTB's repressive activity including: direct binding competition with U2AF 65 at the polypyrimidine tract; propagative binding between high affinity sites; looping of RNA between high affinity sites; inhibition of productive splicing complex assembly across introns or exons [8, 9] . In contrast, until recently only a couple of reports had suggested that PTB might be able to activate some splicing events. However, new insights have been facilitated by splice-sensitive microarrays, which allow quantitative profiling of large numbers of ASEs (alternative splicing events) in parallel, and by UV CLIP (cross-linking immunoprecipitation) followed by highthroughput sequencing, which allows a transcriptome-wide view of RNA-protein interactions [10] . Array analysis of cells in which PTB was knocked down identified large numbers of PTB-regulated ASEs [11, 12] . Although most of these ASEs were conventional targets of PTB repression, there was a substantial minority of PTB-activated events. By combining functional PTB-target events from our array experiments with the specific RNA sequence motifs recognized by each RRM shown below [20] , and the PRI peptide motif recognized by the dorsal surface of RRM2 shown above [28] [29] [30] . (B) Depiction of rat Tpm1 exon 3 and human FAS exon 6. These are well-characterized PTB-repressed exons, as discussed in the text. Known PTB-binding motifs (P3, DY and URE6) are indicated by black boxes, with the sequences shown above. Sequence motifs resembling the optimal selected PTB-binding motifs are shown bold and underlined. In addition, the sequence of an additional C-rich tract upstream of Tpm1 exon 3 is shown. The grey circles represent additional elements needed for repression of the exon [39] , and which bind Mbnl proteins (M. Coelho and C.W.J. Smith, unpublished work). The black circle upstream of P3 is the branch point for exon 3.
with a transcriptome-wide PTB CLIP dataset [13] it was possible to decipher differences in the characteristics of PTBrepressed and PTB-activated cassette exons [12] (Figure 2 ). In agreement with previous work, PTB-repressed exons were associated with PTB-binding upstream of or within the regulated exon. However, in contrast with some well-studied PTB-repressed exons, including α-tropomyosin (Tpm1) exon 3 [14, 15] and SRC N1 exon [16] , we found no general tendency for PTB-binding downstream of repressed exons. In contrast, the newly characterized PTB-activated exons were clearly associated with PTB binding on the downstream side of the exon [12] . These exons had weaker 5 -splice sites than PTB-repressed or control alternative exons, suggesting that PTB binding in the downstream intron might be able to compensate for a weak 5 -splice site. However, by insertion of a PTB-binding site in the upstream intron, the exon became repressed by PTB, and the downstream site was converted from a PTB-binding enhancer into a silencer [12] . PTB joins a growing list of splicing regulatory proteins showing a similar position-dependent activity [10] . This poses a series of questions about how the same protein can have opposite regulatory outcomes depending on the location and number of binding sites, and also how several diverse proteins are able to activate splicing when bound downstream of a weak 5 -splice site [10] . The protein TIA1 can activate splicing by direct contact with U1C protein, thereby assisting U1 snRNP (small nuclear ribonucleoprotein) recruitment [17] . Perhaps other activators contact different components of U1 snRNP to assist its recruitment? Indeed PTB RRM1 and RRM2 have been shown to contact U1 snRNA (small nuclear RNA), albeit in the context of repressing the SRC N1 exon [18] .
Functional domains of PTB
Understanding the molecular function of biological macromolecules is invariably assisted by detailed structural information. Although full-length PTB has eluded highresolution structural determination, the structures of all four PTB RRMs have been determined by NMR, in both free form as well as bound to a hexameric CUCUCU RNA ligand [19] [20] [21] [22] . This has revealed the basis of specificity of RNA recognition by each RRM ( Figure 1A ), as well as interesting features of RRM organization. Notably, while the linkers between RRM1, RRM2 and RRM3 are flexible [23] , RRM3 and RRM4 form a stable di-domain with back to back packing of the two RRMs involving the short linker [20, 22] . This di-domain structure necessitates a loop of at least 15 nt between the two pyrimidine tracts recognized by RRM3 and RRM4; targeted mutations to disrupt the di-domain-packing impair PTBs regulatory activity on SRC splicing [24] . Thus, it appears that the RRMs of PTB may serve not only to recognize specific sequence motifs but also to bring about structural rearrangements of the RNA. Nevertheless, other lines of evidence suggest that PTB has additional effector functions that are distinct from RNA binding.
We previously exploited 'artificial tethering' to map a minimal repressor domain of PTB [25] . The PTB-binding silencer downstream of Tpm1 exon 3 was replaced by a binding site for bacteriophage MS2 coat protein. Repression of the exon by PTB was thereby abrogated, but could be restored by expressing a fusion of PTB-MS2 coat protein. Consistent with the MS2 protein now providing RNAbinding function, deletion analysis showed that three of PTBs four RRMs were dispensable. A minimal repressor domain consisted of just RRM2 and the following inter-RRM linker [25] . We had also found that the protein Raver1, initially identified by yeast 2-hybrid assays as a PTB interactor [26] , was able to strongly promote skipping of Tpm1 exon 3 [27] . We identified four short peptide motifs in Raver1, of the form
LGXXP, which could interact with PTB. The motifs were subsequently referred to as PRI (PTB RRMinteracting) motifs [28] . NMR experiments showed that the high affinity PRI3 motif interacted with PTB RRM2 on its dorsal surface, and that RRM2 was able to form a ternary complex with RNA bound to the β-sheet surface and the PRI3 peptide bound in a shallow hydrophobic groove on the dorsal surface [29] . Much more detailed information about the Raver1-PTB interaction has now been obtained by X-ray crystallography of PTB RRM2 linked via a flexible linker to Raver1 PRI motifs [30] . Fortuitously, the two fusion proteins that crystallized (diffracting to <1.6 Å ; 1 Å = 0.1 nm) contained PRI3 and PRI4, which are the highest and lowest affinity PRI motifs from Raver1. The structural data therefore provide a wealth of information about the recognition of PRIs by PTB RRM2. In particular, the side chain of PTB Tyr 247 is a focal point for apolar contacts from a pair of hydrophobic side chains in the PRI motifs (L 3 and P 6 of PRI3, L 3 and L 5 of PRI4). The importance of Tyr 247 was confirmed by a Y247Q mutation, which caused a loss of Raver1 binding in vitro and a 30% reduction in the activity of the MS2 minimal PTB repressor domain. Perhaps more surprising was that mutation of the RNA-binding surface of RRM2 had an even larger effect in the MS2 assay (60-90% loss of activity), even though the MS2 protein brings the fusion protein to the location of the original PTB-binding site [30] . This raises the question of the RNA site that must be bound by PTB RRM2. One possibility, suggested by in vitro experiments in HeLa extracts, is that the tethered PTB interacts with the pyrimidine tract upstream of exon 3, thereby forming a protein-bridged RNA loop (M. Coelho and C.W.J. Smith, unpublished work). Alternatively, it is possible that the tethered RRM2 interacts with U1 snRNA, as demonstrated for the SRC N1 exon [18] .
We have also used the MS2 approach with PTB-activated exons, initially focusing on an exon in the KTN1 gene [12] . Both full-length PTB as well as RRM2 and the following linker were able to activate inclusion of the KTN1 exon. In contrast, RRM3 and RRM4 fused to MS2 had the opposite effect, slightly increasing exon skipping. Thus, at least for the Tpm1 and KTN1 exons, the minimal repressor and activator domains comprise RRM2 and the following linker. However, the KTN1 exon is not an ideal experimental model since the amplitude of response to PTB knockdown or MS2-PTB recruitment is quite modest. We are therefore repeating these analyses with other exons that are more responsive to PTB, with a view to carrying out a more detailed comparison of minimal repressor and activator domains. We will combine this approach with analyses of protein (and RNA) binding targets of the minimal effectors, as described recently for Rbfox proteins [31] . Using in vitro pull-down assays with recombinant RRM2 wild-type and Y247Q mutant proteins we have already found that a number of other nuclear proteins interact with the surface of PTB RRM2 recognized by PRI motifs (M. Coelho and C.W.J. Smith, unpublished work). These proteins are candidate splicing co-regulators and/or targets of PTB's repressor domain.
Counting proteins in complexes
PTB typically interacts with more than one pyrimidine tract in the region of exons that it represses. To fully understand how PTB functions, it is important to know how many PTB molecules bind to target RNAs. Conventional biochemical assays, such as electrophoretic mobility shift or filter-binding, have shown that splicing substrates typically bind more than one PTB molecule [14] [15] [16] 32] . However, these analyses have used pure recombinant PTB, which could easily lead to overestimates of the true number of molecules bound in vivo, where non-specific binding will be suppressed by the numerous other proteins that coat the RNA. To circumvent this problem, Cherny et al. [14] devised a single molecule approach, using TIRF (total internal reflection fluorescence) microscopy to image the binding of GFP (green fluorescent protein)-tagged PTB to substrate RNAs immobilized on a slide using Cy5-labelled complementary oligonucleotides. The PTB-GFP was present in nuclear extracts from transiently transfected HeLa cells, and PTB-RNA interactions were observed by co-localization of Cy5 and GFP fluorescence. The number of bound PTBs was determined either by analysis of successive photobleaching steps or by modelling cumulative distributions of total photon counts. This approach was used to analyse binding of PTB to substrates containing Tpm1 exon 3, which is flanked by two long pyrimidine tracts that act as PTB-binding silencer elements ( Figure 1B [5, 15] ). The data indicated that 5-6 PTB molecules bound around Tpm1 exon 3, thereby ruling out models for PTB repression involving propagative binding of PTB between the distantly separated high affinity binding tracts [8, 9] . Using the specificities of individual RRM binding to RNA ( Figure 1A [20] ), and assuming a short but flexible separation of sites bound by RRM1, RRM2 and RRM3, we were able to model how three PTBs would bind to the upstream and two to the downstream pyrimidine tract. An important insight was that not only could both of the high affinity tracts accommodate two or three PTB molecules, in agreement with experimental observations, but that there were numerous ways in which this could be achieved, with multiple overlapping arrangements for the specific RRM-RNA contacts. We suggest that the potential for multiple binding configurations may be a hallmark of high affinity-binding sites. Indeed, many motifs enriched in the vicinity of PTB-regulated exons (e.g. UCUCU) [12] have embedded overlapping motifs for individual PTB RRMs. Our model required that the RRM4 domains would contact the RNA outside of the P3 and DY PTB-binding pyrimidine tracts. An additional C-rich tract upstream of exon 3 is a candidate site (Figure 1B) , which is consistent with the observed specificity of RRM4 ( Figure 1A) . In order to test this model, we need an experimental approach that can facilitate systematic determination of the sites contacted by individual RRMs. Such an approach has been developed to interrogate the interaction of PTB with viral IRESs.
Mapping the sites of PTB RRM contacts with IRESs
In contrast with the unpaired pyrimidine tracts that typically mediate splicing repression by PTB, IRESs are highly structured. PTB contacts short pyrimidine-rich loops as well as sequences that are predicted to be at least partially base paired [7] . Despite the higher degree of structural order in IRES-PTB complexes, high-resolution structures of fulllength PTB bound to IRES substrates have not been obtained. Kafasla et al. [33] therefore adapted the tethered hydroxyl radical probing approach, originally used to map binding sites of ribosomal proteins on rRNAs [34] . A battery of PTB mutants were generated, each with a single cysteine residue inserted close to the RNA-binding surface of one of the RRM domains [33] . Modification of cysteine with Fe(II)-BABE [1-(p-bromoacetamido benzyl) EDTA] allows the localized generation of short-lived reactive hydroxyl radicals, which can cleave the RNA backbone within a limited distance (∼ 10-35 Å ). Mapping the cleavage sites by reverse transcription primer extension reveals the region of the RNA contacted by individual RRMs. This approach was applied to the highly structured EMCV (encephalomyocarditis virus) and PV (poliovirus) IRESs [33, 35] . Combined with nondenaturing MS, which revealed that two PTBs bind to the EMCV IRES, but only one to the PV IRES, this allowed for the first time the positions of individual PTB RRMs to be mapped on to the distinct RNA structural domains of the two IRESs (Figure 3 ). The importance of individual RRM-RNA contacts was next tested by combining mutations designed to disrupt RNA binding by individual RRMs, with the single cysteine mutants to report on the RNA contacts by the mutated RRM and the remaining functional RRMs [36] . Inactivation of any individual RRM domain reduced affinity modestly but did not impair or reposition RNA contacts by the remaining RRMs. However, the effects upon IRES activity were variable. For EMCV, only mutation of RRM2 led to full loss of activity; mutation of RRM1, RRM3 or RRM4 had moderate effects, but combined mutation of RRM3 and RRM4 eliminated activity. In contrast, the PV IRES was inactivated by mutations of RRM1, RRM2 or RRM4, but tolerated mutation of RRM3 surprisingly well. RRM1 and RRM2 mapped to the structured region of domain V of the PV IRES, adjacent to the site of eIF4G (eukaryotic initiation factor 4G) binding; in contrast, RRM3 and RRM4 contacted the single-stranded regions flanking the base of domain V. This agrees with independent reports that RRM1 and RRM2 favour structured RNAs while RRM3 and RRM4 bind better to single-stranded pyrimidine tracts [37] . Moreover, PTB and eIF4G were seen to reciprocally modulate each other's position of binding, suggesting that PTB activation of the PV IRES involves optimizing the position of eIF4G for translation initiation just downstream of domain V [35] .
Going forward-tethered probing of splicing substrates
The set of PTB single cysteine mutants for tethered hydroxyl radical probing, combined with the RRM mutations to selectively impair RNA binding by individual RRMs, can potentially be applied to various PTB substrate RNAs involved in other steps of gene expression, including PTBregulated ASEs. We initially attempted to use tethered hydroxyl radical probing to investigate the sites at which individual PTB RRMs contact the Tpm1 RNA. However, under a wide range of conditions, it was difficult to detect specific signals (P. Kafasla, unpublished work); despite the fact that we know that five to six PTB molecules bind to this substrate [14] . However, Tpm1 might be a particularly challenging substrate for this kind of analysis due to the large number of bound PTBs. It is likely that there are numerous different binding arrangements for the multiple RRMs interacting with the extended pyrimidine tracts, which would produce poor signal-to-noise ratio in the tethered probing assay. For this reason, we are applying tethered probing to FAS exon 6 [38] , in which a single 16 nt exonic sequence (referred to as URE6) is the only known element required for PTB-induced exon skipping ( Figure 1B) . Skipping of FAS exon 6 in HeLa nuclear extracts is promoted by the addition of recombinant PTB, thereby allowing monitoring of functional activity, as well as RRM-RNA contacts by the modified single-cysteine PTBs. Moreover, the single-molecule TIRF approach can be used to determine the stoichiometry of PTB-RNA interactions [14] , which is necessary for interpretation of the probing data. As discussed at the RNA UK 2012 meeting, these combined approaches are now allowing us to build a picture of how the RRMs of PTB interact with the FAS RNA, both within URE6 and at previously unidentified locations, to promote exon skipping. 
